SEARCH

SEARCH BY CITATION

References

  • 1
    Schmitt J, Spuls P, Boers M et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012; 67:111117.
  • 2
    Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol 2004; 140:151319.
  • 3
    Charman CR, Williams HC. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000; 136:7639.
  • 4
    Charman CR, Chambers C, Williams HC. Measuring atopic dermatitis severity in randomised controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003; 120:93241.
  • 5
    Ricci G, Dondi A, Patrizi A. Useful tools for the management of atopic dermatitis. Am J Clin Dermatol 2009; 10:287300.
  • 6
    Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120:138998.
  • 7
    Williams HC, Grindlay DJC. What's new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 1. Definitions, causes and consequences of eczema. Clin Exp Dermatol 2009; 35:1215.
  • 8
    National Institute for Health and Clinical Excellence. Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years. December 2007. Available at: http://guidance.nice.org/CG57 (last accessed October 2013).
  • 9
    Thomas KS, Koller K, Dean T et al. A multicentre randomized controlled trial of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technol Assess 2011; 15:1156.
  • 10
    Schram ME, Roekevisch E, Leeflang MM et al. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011; 128:3539.
  • 11
    Armstrong AW, Kim RH, Idriss NZ et al. Online video improves clinical outcomes in adults with atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 2011; 64:5027.
  • 12
    Schram ME, Spuls PI, Leeflang MMG et al. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012; 67:99106.
  • 13
    Williams HC, Burney PG, Hay RJ et al. The UK Working Party's diagnostic criteria for atopic dermatitis. Br J Dermatol 1994; 131:383416.
  • 14
    Hongbo Y, Thomas CL, Harrison MA et al. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125:65964.
  • 15
    European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186:2331.
  • 16
    Tofte S, Graeber M, Cherill R et al. Eczema area and severity index (EASI): a new tool to evaluate atopic dermatitis. J Eur Acad Dermatol Venereol 1998; 11(Suppl. 2):48.
  • 17
    Charman CR, Venn AJ, Williams HC et al. Measuring atopic eczema severity visually; which variables are most important to patients? Arch Dermatol 2005; 141:114651.